MedEquities Realty Trust (NYSE:MRT) Director Bluemountain Capital Managemen sold 20,000 shares of the business’s stock in a transaction on Friday, May 18th. The stock was sold at an average price of $10.40, for a total transaction of $208,000.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.
Bluemountain Capital Managemen also recently made the following trade(s):
Get MedEquities Realty Trust alerts: On Monday, May 21st, Bluemountain Capital Managemen sold 57,666 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $10.33, for a total transaction of $595,689.78. On Wednesday, May 16th, Bluemountain Capital Managemen sold 18,346 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $10.32, for a total transaction of $189,330.72. On Monday, May 14th, Bluemountain Capital Managemen sold 19,316 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $10.48, for a total transaction of $202,431.68. On Thursday, May 10th, Bluemountain Capital Managemen sold 64,088 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $10.51, for a total transaction of $673,564.88. On Tuesday, May 8th, Bluemountain Capital Managemen sold 91,623 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $10.25, for a total transaction of $939,135.75. On Friday, May 4th, Bluemountain Capital Managemen sold 17,674 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $10.16, for a total transaction of $179,567.84. On Tuesday, May 1st, Bluemountain Capital Managemen sold 24,739 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $10.17, for a total transaction of $251,595.63.MedEquities Realty Trust traded down $0.16, reaching $10.29, during trading on Monday, according to MarketBeat Ratings. 100,300 shares of the stock were exchanged, compared to its average volume of 157,112. The company has a market cap of $333.22 million, a price-to-earnings ratio of 9.03 and a beta of -0.18. MedEquities Realty Trust has a twelve month low of $9.67 and a twelve month high of $13.06.
MedEquities Realty Trust (NYSE:MRT) last issued its earnings results on Thursday, May 10th. The financial services provider reported $0.16 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.30 by ($0.14). The firm had revenue of $16.72 million for the quarter, compared to analyst estimates of $16.41 million. MedEquities Realty Trust had a return on equity of 6.17% and a net margin of 34.63%. analysts predict that MedEquities Realty Trust will post 1.2 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 5th. Shareholders of record on Tuesday, May 22nd will be issued a $0.21 dividend. The ex-dividend date is Monday, May 21st. This represents a $0.84 annualized dividend and a dividend yield of 8.16%. MedEquities Realty Trust’s dividend payout ratio is currently 73.68%.
Several large investors have recently added to or reduced their stakes in the business. Teachers Insurance & Annuity Association of America increased its holdings in shares of MedEquities Realty Trust by 26.5% in the first quarter. Teachers Insurance & Annuity Association of America now owns 37,703 shares of the financial services provider’s stock valued at $396,000 after purchasing an additional 7,903 shares during the last quarter. UBS Group AG increased its holdings in shares of MedEquities Realty Trust by 52.3% in the first quarter. UBS Group AG now owns 23,234 shares of the financial services provider’s stock valued at $244,000 after purchasing an additional 7,978 shares during the last quarter. LSV Asset Management acquired a new position in shares of MedEquities Realty Trust in the fourth quarter valued at $103,000. JPMorgan Chase & Co. acquired a new position in shares of MedEquities Realty Trust in the third quarter valued at $118,000. Finally, Wells Fargo & Company MN increased its holdings in shares of MedEquities Realty Trust by 43.4% in the third quarter. Wells Fargo & Company MN now owns 35,366 shares of the financial services provider’s stock valued at $416,000 after purchasing an additional 10,700 shares during the last quarter. Hedge funds and other institutional investors own 93.54% of the company’s stock.
MRT has been the topic of a number of research reports. Cantor Fitzgerald reissued a “buy” rating and issued a $14.00 price objective on shares of MedEquities Realty Trust in a research report on Wednesday, February 21st. B. Riley set a $13.00 target price on shares of MedEquities Realty Trust and gave the stock a “buy” rating in a report on Thursday, February 22nd. ValuEngine downgraded shares of MedEquities Realty Trust from a “buy” rating to a “hold” rating in a report on Friday, February 23rd. Citigroup lowered their target price on shares of MedEquities Realty Trust from $12.00 to $10.00 and set a “neutral” rating on the stock in a report on Thursday, March 1st. Finally, KeyCorp lowered their target price on shares of MedEquities Realty Trust from $13.00 to $12.00 and set an “overweight” rating on the stock in a report on Monday, April 16th. One analyst has rated the stock with a sell rating, three have issued a hold rating and four have given a buy rating to the stock. The company currently has an average rating of “Hold” and an average price target of $12.43.
About MedEquities Realty Trust
MedEquities Realty Trust (NYSE: MRT) is a self-managed and self-administered real estate investment trust that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company's management team has extensive industry experience in acquiring, owning, developing, financing, operating, leasing and monetizing many types of healthcare properties and portfolios.
No comments:
Post a Comment